Menu
United States of America
  • United States of America
  • Adriatic
  • Arabia
  • Argentina
  • Australia and New Zealand
  • Bangladesh
  • Belgique (Belgium) - Français
  • België (Belgium) - Nederlands
  • Brasil (Brazil)
  • Bulgaria
  • Canada - English
  • Canada - Français
  • Chile
  • Colombia
  • Costa Rica
  • Danmark (Denmark)
  • Deutschland (Germany)
  • Ecuador
  • España (Spain)
  • Europe
  • Europe Central/Eastern, Middle East & Africa
  • France
  • Indian Subcontinent
  • Ireland
  • Israel  ישראל
  • Italia (Italy)
  • Latinoamérica
  • Magyarország (Hungary)
  • México (Mexico)
  • Nederland (Netherlands)
  • Norge (Norway)
  • Panama
  • Paraguay
  • Perú (Peru)
  • Philippines
  • Polska (Poland)
  • Portugal
  • Puerto Rico
  • Romania
  • Schweiz (Switzerland) - Deutsch
  • Singapore
  • Slovenská republika (Slovak Republic)
  • South Africa and Sub-Sahara
  • Suisse (Switzerland) - Français
  • Suomi (Finland)
  • Sverige (Sweden)
  • Thailand
  • Türkiye (Turkey)
  • United Kingdom
  • Uruguay
  • Vietnam
  • Österreich (Austria)
  • Česká republika (Czech Republic)
  • Ελλάδα (Greece)
  • Российская Федерация (Russia)
  • Србија (Serbia)
  • Україна (Ukraine)
  • 中国 (China)
  • 台灣地區 (Taiwan)
  • 日本 (Japan)
  • 香港特區 (Hong Kong SAR)
  • 대한민국 (South Korea)
United States of America
  • United States of America
  • Adriatic
  • Arabia
  • Argentina
  • Australia and New Zealand
  • Bangladesh
  • Belgique (Belgium) - Français
  • België (Belgium) - Nederlands
  • Brasil (Brazil)
  • Bulgaria
  • Canada - English
  • Canada - Français
  • Chile
  • Colombia
  • Costa Rica
  • Danmark (Denmark)
  • Deutschland (Germany)
  • Ecuador
  • España (Spain)
  • Europe
  • Europe Central/Eastern, Middle East & Africa
  • France
  • Indian Subcontinent
  • Ireland
  • Israel  ישראל
  • Italia (Italy)
  • Latinoamérica
  • Magyarország (Hungary)
  • México (Mexico)
  • Nederland (Netherlands)
  • Norge (Norway)
  • Panama
  • Paraguay
  • Perú (Peru)
  • Philippines
  • Polska (Poland)
  • Portugal
  • Puerto Rico
  • Romania
  • Schweiz (Switzerland) - Deutsch
  • Singapore
  • Slovenská republika (Slovak Republic)
  • South Africa and Sub-Sahara
  • Suisse (Switzerland) - Français
  • Suomi (Finland)
  • Sverige (Sweden)
  • Thailand
  • Türkiye (Turkey)
  • United Kingdom
  • Uruguay
  • Vietnam
  • Österreich (Austria)
  • Česká republika (Czech Republic)
  • Ελλάδα (Greece)
  • Российская Федерация (Russia)
  • Србија (Serbia)
  • Україна (Ukraine)
  • 中国 (China)
  • 台灣地區 (Taiwan)
  • 日本 (Japan)
  • 香港特區 (Hong Kong SAR)
  • 대한민국 (South Korea)
  • Healthcare Professionals
    • Overview
    • Products
      • Overview
      • Access Instruments
      • Bladder & Bowel
      • Cardiac Rhythm & Diagnostics
      • Cardiovascular
      • Diabetes
      • Digestive & Gastrointestinal
      • Ear, Nose & Throat
      • Gynecological
      • Hernia Repair
      • Lung Health & Thoracic Surgery
      • Neurological
      • Patient Monitoring
      • Respiratory
      • Spinal & Orthopedic
      • Surgical Energy
      • Surgical Navigation & Imaging
      • Surgical Robotics
      • Surgical Stapling
      • Wound Closure
    • Specialties
      • Overview
      • Acute Care & Monitoring Solutions
      • Bariatric Surgery
      • Bladder & Bowel Solutions
      • Colon & Rectal Surgery
      • Diabetes
      • Ear, Nose & Throat
      • Electrophysiology
      • Federal Healthcare Solutions
      • Gastroenterology
      • Gynecology
      • Hernia Repair Surgery
      • Interventional Cardiology
      • Lung Health & Thoracic Surgery
      • Neurology
      • Pain Management
      • Spine Surgery
      • Surgical Robotics
      • Touch Surgery™ Ecosystem
    • Services
      • Overview
      • Medtronic Financial Services
      • Office-Based Labs
      • Physician Collaboration
    • Digital Ordering & Services
      • Overview
      • Electronic Data Interchange
      • Order Online
      • Digital Services
    • Education & Training
      • Overview
      • Medtronic Academy
      • Genius Academy
      • MedEd Bytes
      • MedEd Learning Experience Podcast Series
    • MRI Resources
      • Overview
      • MR Conditional Search Tool
      • Implantable Cardiac Devices
      • Neurological Shunts
      • Reveal LINQ™ ICM MRI Conditions
    • Product Resources
      • Overview
      • Product Advisories & Performance
      • Product Compatibility
      • Product Identification
      • Product Stewardship
      • Product Warranty Information
      • Scientific Publications
      • External Research Program
    • Reimbursement
      • Overview
      • Reimbursement Directory
      • C-Code Finder
      • Cardiac Rhythm Management & Catheter Ablation
      • Cardiovascular
      • Diabetes
      • Ear, Nose & Throat
      • Interventional Spine Surgery
      • Medical Surgical
      • Neurological
      • SpineLine™ Spinal and Orthopedic Reimbursement Support
      • Urological & Urogynecological
  • Patients & Caregivers
    • Overview
    • Conditions Overview
      • Overview
      • Airway & Lung
      • Brain
      • Diabetes
      • Digestive & Gastrointestinal
      • Ear, Nose & Throat
      • Gynecologic Health
      • Heart & Vascular
      • Kidney & Liver
      • Pain
      • Spine & Orthopedic
      • Urinary
    • Treatments & Therapies
      • Overview
      • Airway & Lung
      • Brain
      • Diabetes
      • Digestive & Gastrointestinal
      • Ear, Nose & Throat
      • Gynecologic Health
      • Heart & Vascular
      • Kidney & Liver
      • Mouth & Dental
      • Pain
      • Spine & Orthopedic
      • Urinary
      • Weight Loss & Obesity
    • Medtronic Patient Services
      • Overview
      • Contact Patient Services
      • Return Explanted Products Form
      • Monitor Troubleshoot Request
      • Product Returns & Replacements
    • Electromagnetic Compatibility (EMC)
      • Overview
      • Communications & Office Equipment
      • Frequently Asked Questions
      • Household & Hobby Items
      • Medical & Dental Procedures
      • Tools & Industrial Equipment
      • Additional Resources
    • What Is a Humanitarian Device?
    • MRI SureScan
    • MRI Access
    • Manage Your ID Card
      • Overview
      • Request New ID Card
    • Health Monitoring
      • Overview
      • About Health Monitoring
      • Personal Stories
      • Interview Patient Resources
  • Our Company
    • Overview
    • Who We Are
    • Mission
    • Governance
      • Overview
      • Overview
      • Board & Committees
      • Principles & Ethics
      • Suppliers
      • Grants & Donations
      • Distributor Compliance
    • Leadership
    • Investors
    • Key Facts
    • History
    • Locations
    • News
    • Careers
      • Overview
      • Overview
      • Culture
      • Engineer Your Career
      • Early Careers
      • Inclusion & Diversity
  • Our Impact
    • Overview
    • Our Impact
    • Impact Reporting
    • Health Equity
    • Inclusion, Diversity & Equity
    • Planet
    • Communities
Contact & Support
  1. Our Company
  2. Governance
  3. Board & Committees
  4. Nominating & Corporate Governance Committee Charter
Abstract dots
Board and committees

Nominating and Corporate Governance Committee Charter

  

Menu

  • Overview
  • Board & Committees
  • Principles & Ethics
  • Suppliers
  • Grants & Donations
  • Distributor Compliance
    • Overview
    • Board & Committees
    • Principles & Ethics
    • Suppliers
    • Grants & Donations
    • Distributor Compliance

(As amended through March 7, 2024)

Purpose

Medtronic plc (the “Company”) is a publicly-held company and operates in a complex, dynamic, highly competitive, and regulated environment. The business and affairs of the Company are governed by (or under the direction of) a Board of Directors (“Board”), and therefore the recommendation and selection of qualified individuals to be Board members is crucial to the successful operation of the Company. The Nominating and Corporate Governance Committee’s (the “Committee”) primary purposes are to carry out and perform the responsibilities and duties delegated by the Board relating to the Company’s director nomination process, development and oversight of the Company’s corporate governance policies, and any corporate governance-related matters required by the U.S. securities laws, NYSE listing standards, and Irish law, as set forth in this Charter.

Members

The Committee will consist of three or more directors, each of whom the Board has determined meets the independence requirements of the New York Stock Exchange (“NYSE”) and the Securities and Exchange Commission (the “SEC”), and one of which will be the Lead Independent Director, as elected by the Board. The members of the Committee are appointed by the Board and serve until their successors are duly appointed in connection with a change in Committee composition or until they are no longer on the Board. The Lead Independent Director, as elected by the Board, will be the Chair of the Committee.  The Chair of the Board and the Chief Executive Officer of the Company are permitted to attend all Committee meetings.

Duties and Responsibilities

The Committee has the following responsibilities and duties:

  1. Identification, Evaluation and Recommendation of Board Candidates
    1. Formulate the Company’s policies and procedures for identifying a diverse pool of qualified director candidates and for evaluating and recommending candidates, including consideration of candidates recommended by shareholders and the other directors, to be considered by the Board for nomination at an annual or extraordinary general meeting of shareholders or for election by the Board to fill a vacancy existing on the Board. 
    2. As necessary, identify, evaluate and recommend to the Board qualified individuals for (i) the Board to nominate for election as directors at either an annual general meeting or an extraordinary general meeting of shareholders, and (ii) election by the Board to fill vacancies or expand the number of directors on the Board. Candidates selected for nomination to the Board by the Company will meet the criteria approved by the Board and articulated in the Company’s Principles of Corporate Governance (the “Principles”).
    3. Review and make recommendations to the Board whether members of the Board should stand for re-election, with consideration to the annual independence review, the criteria articulated in the Principles, and the current size and composition of the Board.
    4. Administer the process outlined in the Company’s Articles of Association concerning shareholder nominations for director candidates.
    5. Consider matters relating to the retirement of members of the Board, including term limits or age limits.
    6. Consider any resignation offered by a director who changes the primary career responsibility he or she held when elected to the Board, and recommend to the Board whether to accept such resignation.
  2. Board Structure and Organization
    1. Develop an annual evaluation process for the Board and its committees and oversee the execution of such annual evaluations, including the Committee’s own evaluation.
    2. Recommend to the Board, in accordance with the policies and procedures outlined in the Principles, directors qualified to serve as members of each committee and as committee chairs.
    3. Review periodically, but at least annually, the size and composition of the Board and each standing committee and recommend to the Board such changes that the Committee deems necessary for the proper governance of the Company.
    4. Consider the number of regular Board meetings to be held during each year and recommend to the Board such increases or decreases that the Committee deems appropriate.
  3. Corporate Governance
    1. Review the Principles at least annually, including practices and procedures related to board leadership structure and management succession planning, and recommend to the Board changes as the Committee deems desirable, based on all applicable laws, rules, listing standards, and best practices.
    2. Monitor emerging corporate governance trends, oversee and evaluate the Company’s corporate governance policies and programs, and recommend to the Board such changes as the Committee believes desirable.
    3. Review, in accordance with the Company’s Related Party Transaction Policies and Procedures, transactions and relationships with related parties that are required to be approved or ratified thereunder.
    4. Review the Company’s Related Party Transaction Policies and Procedures on a periodic basis and recommend to the Board changes as the Committee deems desirable, based on all applicable laws, rules, listing standards and best practices.
    5. Review shareholder proposals and recommend to the Board proposed Company responses to such proposals for inclusion in the Company’s proxy statement or otherwise.
    6. Review periodically as it deems appropriate, but at least annually, the independence requirements issued by the NYSE and by other applicable regulators and advisory services and provide to the Board the Committee’s assessment of which directors should be deemed independent directors under applicable rules, standards, and regulations.
    7. Review periodically as it deems appropriate, but at least annually, the requirements of an “audit committee financial expert” under applicable rules of the SEC and NYSE, assess which directors should be deemed audit committee financial experts and recommend to the Board the determination that such directors are “audit committee financial experts.”
    8. Oversee and review on a periodic basis the continuing education program for directors and the orientation program for new directors.
    9. Conduct an annual performance evaluation of the Committee in such manner as the Committee deems appropriate.
    10. Review this charter annually and recommend to the Board any revisions to this charter deemed necessary or desirable.
  4. Other Responsibilities
    1. Review and provide advice to the Board on matters relating to director compensation, including compensation philosophy and the components of compensation for directors, and recommend director compensation and benefits and changes to director compensation and benefits to the Board.
    2. Review stock ownership guidelines for directors and, as appropriate, recommend changes to the Board. Monitor compliance by directors with the Company’s stock ownership guidelines.
    3. Review, in accordance with and as frequently as required by the Company’s Political Contribution Policy, the Company’s corporate political contributions.
    4. As it determines appropriate, review the Company’s actions and governance policies in furtherance of its corporate social responsibility, including considering the sustainability and impact of the Company’s business operations on employees, citizens, communities and the environment.
    5. Review the Company’s philanthropic activities, including charitable contributions.
    6. Perform such other functions as assigned by applicable law, regulations, listing standards, the Company’s Articles of Association, or the Board.

Meetings

The Committee will meet as often as may be deemed necessary or appropriate in its judgment, but not less frequently than four times per year, either in person, telephonically or virtually, and at a place and time determined by the Committee. The Committee may request any director, officer or employee of the Company or the Company’s outside counsel to attend a meeting of the Committee or to meet with any members of, or consultants to, the Committee. The Committee will report on its activities to the Board regularly.

Compensation

The compensation of Committee members will be as determined by the Board.

Delegation

The Committee may, in its discretion, form and delegate authority to subcommittees, including a single member, when appropriate and consistent with applicable law.  Any actions taken by a subcommittee will be reported to the full Committee at its next meeting.

The duty to oversee an annual evaluation of the performance of management, included in the NYSE Listed Company Manual as a duty of the Committee, has been delegated to the Compensation Committee.

Authority

The Committee will have the authority appropriate to discharge its duties and responsibilities, including retaining outside counsel, outside search firms and any other advisors as the Committee may deem appropriate in its sole discretion. The Committee will have sole authority to retain and terminate any such counsel, search firm or advisor, including sole authority to approve its fees and other retention terms.

  • Share
  • Print
  • Mail
  • Link
  • Facebook
  • LinkedIn
  • Close
contactUs
There are items that require your attention.
There are items that require your attention.
There are items that require your attention.
There are items that require your attention.
There are items that require your attention.

Your information will be used and protected in accordance with our privacy notice.

There are items that require your attention.
United States

Customer Care Team

Hours: 8:00 a.m. - 8:00 p.m. EST 

 

Phone: 763-514-4000

Toll-free: 800-633-8766

There are items that require your attention.
There are items that require your attention.
There are items that require your attention.

Just to confirm, is this the product or product type that interests you?

{{productNamePlaceholder}}

OR

There are items that require your attention.

OR

There are items that require your attention.

There are items that require your attention.

OR

There are items that require your attention.
There are items that require your attention.

There are items that require your attention.
There are items that require your attention.

OR

There are items that require your attention.

Before we get started, what best describes you?

OR

There are items that require your attention.

OR

OR

There are items that require your attention.

Before we get started, what best describes you?

OR

There are items that require your attention.
There are items that require your attention.
There are items that require your attention.
There are items that require your attention.
There are items that require your attention.

If you subscribe to email updates, you can unsubscribe anytime via the link in each email. We use technology to measure email opens and clicks, to improve our communications and provide relevant content. For details, see our privacy notice.

There are items that require your attention.

Your personal data will be used to manage your relationship with Medtronic in accordance with our privacy notice.

There are items that require your attention.

Before we get started, what best describes you?

OR

There are items that require your attention.
There are items that require your attention.
There are items that require your attention.
There are items that require your attention.
There are items that require your attention.
There are items that require your attention.

If you consent to receive emails, you can unsubscribe anytime via the link in each email. We use technology that measures email opens and clicks, to improve our communications and provide relevant content. For details, see our privacy notice.

  • Careers
  • Contact & Support
  • Order Products (open in new window)
  • Diabetes Supplies (open in new window)
  • Product Manuals (open in new window)
  • Product Security (open in new window)
  • Information About Proposition 65 for California Customers (open in new window)
  • Digital Millennium Copyright Act (DMCA) Notification
Engineering the extraordinary
  • Facebook
  • Youtube
  • Linkedin
  • Privacy Notice
  • Terms of Use
  • Accessibility Statement
Operational Headquarters 710 Medtronic Parkway, Minneapolis, MN 55432-5604 USA

©2025 Medtronic